CHITI, ARTURO
 Distribuzione geografica
Continente #
AS - Asia 5.658
EU - Europa 5.305
NA - Nord America 4.336
SA - Sud America 942
Continente sconosciuto - Info sul continente non disponibili 688
AF - Africa 137
OC - Oceania 40
Totale 17.106
Nazione #
US - Stati Uniti d'America 4.080
RU - Federazione Russa 2.993
SG - Singapore 2.181
CN - Cina 1.620
IT - Italia 1.181
BR - Brasile 780
HK - Hong Kong 606
VN - Vietnam 375
BD - Bangladesh 363
FR - Francia 234
DE - Germania 193
GB - Regno Unito 165
IN - India 123
CA - Canada 122
NL - Olanda 99
FI - Finlandia 98
MX - Messico 81
SE - Svezia 73
ES - Italia 60
JP - Giappone 58
AT - Austria 55
AR - Argentina 52
ZA - Sudafrica 43
PL - Polonia 41
AU - Australia 39
TR - Turchia 35
PK - Pakistan 32
MA - Marocco 31
IQ - Iraq 30
MY - Malesia 29
ID - Indonesia 28
EC - Ecuador 27
SA - Arabia Saudita 27
AE - Emirati Arabi Uniti 21
LT - Lituania 21
CO - Colombia 20
MD - Moldavia 20
UZ - Uzbekistan 19
VE - Venezuela 17
EG - Egitto 16
CL - Cile 15
PH - Filippine 15
PY - Paraguay 14
DZ - Algeria 13
JM - Giamaica 13
JO - Giordania 12
TH - Thailandia 12
UA - Ucraina 12
TN - Tunisia 11
DK - Danimarca 9
IL - Israele 9
TW - Taiwan 9
CR - Costa Rica 8
NP - Nepal 8
BE - Belgio 7
HN - Honduras 7
KE - Kenya 7
BO - Bolivia 6
NI - Nicaragua 6
PE - Perù 6
CH - Svizzera 5
GE - Georgia 5
HR - Croazia 5
KR - Corea 5
PT - Portogallo 5
UY - Uruguay 5
BG - Bulgaria 4
IE - Irlanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
CG - Congo 3
KH - Cambogia 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
QA - Qatar 3
RO - Romania 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MM - Myanmar 2
SN - Senegal 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
Totale 16.399
Città #
Singapore 1.182
Ashburn 676
Moscow 664
San Jose 654
Hong Kong 587
Dallas 534
Shanghai 299
Milan 286
Beijing 250
New York 240
Hefei 228
Lauterbourg 192
Los Angeles 146
Ho Chi Minh City 121
Santa Clara 115
Rome 114
Hanoi 88
Council Bluffs 77
São Paulo 62
Orem 56
Nuremberg 53
Seattle 53
Munich 52
Boardman 51
Chennai 46
Tokyo 42
Montreal 41
Denver 40
Washington 40
Helsinki 39
Turku 39
London 38
Brooklyn 37
Mexico City 35
Warsaw 33
Amsterdam 32
Naples 32
Bologna 31
Frankfurt am Main 31
Atlanta 30
Chicago 30
Johannesburg 30
Buffalo 29
Toronto 26
Phoenix 25
Poplar 25
Stockholm 25
The Dalles 23
Belo Horizonte 22
Houston 22
Florence 21
Guangzhou 21
Brescia 20
Canberra 20
Lappeenranta 20
Las Vegas 20
Rio de Janeiro 20
Manchester 19
San Francisco 19
Valencia 19
Vienna 19
Hangzhou 18
Da Nang 17
Tashkent 17
Ankara 16
Assago 16
Cesano Boscone 16
Mumbai 16
Omaha 16
Princeton 16
Shenzhen 16
Genoa 15
Haiphong 15
Lawrence 15
Memphis 15
Turin 15
Abu Dhabi 14
Biên Hòa 14
Charlotte 14
Sydney 14
Tianjin 14
Falkenstein 13
Quito 13
Kuala Lumpur 12
Querétaro 12
Amman 11
Bari 11
City of London 11
Miami 11
Wuhan 11
Bang Kruai 10
Boston 10
Curitiba 10
Dalian 10
Fortaleza 10
Jeddah 10
Riyadh 10
St Louis 10
Campinas 9
Dhaka 9
Totale 8.353
Nome #
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 295
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 257
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 189
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 169
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 157
A Multimodal Protocol Combining 99mTc-Tilmanocept with Indocyanine Green Fluorescence Lympho-Angiography for Sentinel Lymph Node Biopsy in Early-Stage Oral Cancer: A Case Series. 157
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 155
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 148
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 134
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis 133
Data-Driven Motion Correction of 11C-Methionine PET Images on a Cohort of Pediatric Patients With Brain Tumor in a PET/MRI Study 133
Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study 129
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 126
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 124
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach 123
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 123
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 123
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 122
Challenging the significance of SUV-based parameters in a large-scale retrospective study on lung lesions 121
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 121
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 120
Prognostic Value of Metabolic Imaging Data of 11C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 120
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 120
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis 119
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 116
Cutting back on overdiagnosis – Occam’s Razor and unspecific bone uptakes in PSMA PET 116
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 115
Malignant pleural effusion (MPE) characterized with 11C-Methionine PET/CT before and after talc pleurodesis: interim evaluation of a prospective clinical trial 115
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 113
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 111
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 109
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 108
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 105
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 104
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 104
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 104
Senna intoxication as a cause of extrapontine myelinolysis mimicking rapidly progressive dementia: a case description 104
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 103
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 103
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 103
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 102
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 101
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 101
Smaller is better? Compact vs. Conventional gamma camera for sentinel lymph node localization in patients with breast cancer 100
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 100
The diagnostic and prognostic value of tau-PET in amnestic MCI with different FDG-PET subtypes 99
[18F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial 99
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 98
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 98
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 94
A reflection on journal rankings 94
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 93
Absorbed dose from daily routine practice in an 18F-FDG producing radiopharmacy 93
Radioguided Surgery for Prostate Cancer 91
Correction: Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 91
Advancing EJNMMI: continuing success and next developments 89
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 89
Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies 88
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 87
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 87
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 84
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers 83
New Mitral Regurgitation Unveiling Infective Endocarditis in an Adolescent With Mitral Valve Prolapse 83
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 83
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 83
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper 80
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 78
Biological characterization of renal masses using immuno-PET 76
Radiomics of Liver Metastases: A Systematic Review 76
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 75
Perceived risk and decision-making: navigating uncertainty in clinical practice 75
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 75
Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study 74
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 74
Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study 74
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 74
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 74
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 73
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 72
Enhancing NSCLC Histological Subtype Classification: A Federated Learning Approach Using Triplet Loss 72
The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas 72
C-11-Methionine uptake in secondary brain epilepsy 71
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 71
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 69
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 69
Case Report: A Challenging Localization of a Pulmonary Ectopic ACTH-Secreting Tumor in a Patient With Severe Cushing’s Syndrome 69
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 68
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 68
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 68
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 67
EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites 67
Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19 66
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 66
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 66
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 66
Myocardial involvement in systemic sclerosis 66
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 66
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 65
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 64
Explainable domain transfer of distant supervised cancer subtyping model via imaging-based rules extraction 64
Totale 10.031
Categoria #
all - tutte 81.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225 0 0 0 5 0 0 0 0 0 0 0 0
2022/2023466 34 16 7 0 0 5 2 6 8 52 324 12
2023/20241.042 16 78 110 70 81 164 63 119 61 76 54 150
2024/20253.042 296 93 38 94 157 297 347 269 522 431 252 246
2025/202611.840 798 751 668 1.368 954 410 1.257 819 2.854 741 539 681
2026/2027697 672 25 0 0 0 0 0 0 0 0 0 0
Totale 17.106